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ABSTRACT 
 
This thesis, which consists of four original publications and a summary, explores the 
feasibility of combining different unconventional ionization techniques and sample 
preparation methods to improve the sensitivity of liquid chromatography–mass 
spectrometry (LC–MS) based bioanalytical assays. It addresses important sensitivity-
limiting factors, such as the weak electrospray ionization (ESI) of non-polar analytes, 
ion-suppressing effect of ion-pairing mobile phase additives, and the loss of analytes 
during sample pre-processing.  
 The study demonstrates the suitability of using an atmospheric pressure 
chemical ionization (APCI) source without a corona discharge for the efficient 
ionization of selected analytes in the presence of ion-pairing agents. This rarely used 
technique, termed atmospheric pressure thermospray ionization or no-discharge 
APCI, is also shown to be suitable for use with a novel microchip heated nebulizer. 
Moreover, oxime derivatization is presented as a simple and efficient method to 
improve the proton affinity and thus the ESI ionization of non-polar ketosteroids. 
Small-scale liquid-liquid extraction and direct injection can be utilized to increase the 
recovery in the sample preparation process. By combining the above techniques, 
three different assays were developed and their performance was evaluated by 
validation. The assays were also used for the analysis of samples from clinical and 
animal studies.  
 Taken together, this thesis presents alternative or complementary approaches 
for bioanalytical LC–MS method development. The assays developed represent 
significant improvements in sensitivity, dynamic range, and robustness and the 
novel findings regarding ionization in particular provide important new information 
about some rarely used analytical techniques. 
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TIIVISTELMÄ 
 
Tässä neljästä osajulkaisusta ja niiden yhteenvedosta koostuvassa väitöskirjatyössä 
tutkittiin erilaisten näytteenkäsittely- ja ionisaatiotekniikoiden soveltuvuutta 
bioanalyyttisten nestekromatografia–massaspektrometriamenetelmien (LC–MS) 
suorituskyvyn lisäämiseen. Tutkimuksessa pyrittiin löytämään ratkaisuja 
tunnettuihin mittausmenetelmän herkkyyttä heikentäviin tekijöihin, kuten 
poolittomien yhdisteiden heikkoon ionisaatioon sähkösumutuksessa (ESI), ionipari-
reagenssien aiheuttamaan ionisupressioon sekä analysoitavien yhdisteiden 
puutteelliseen saantoon näytteen esikäsittelyn aikana.  
 Tutkimuksen mukaan eräiden lääkeaineiden ja endogeenisten yhdisteiden 
analysoinnissa voidaan hyödyntää ilmanpaine-kemiallinen ionisaatio (APCI) 
tekniikkaa täysin ilman sen toimintaan olennaisesti liittyvää koronapurkausta. 
Tuloksena on ESI:n kaltainen ionisaatio, joka toisin kuin ESI-tekniikka yleensä, 
mahdollistaa ioniparireagenssien käytön ajoliuoksessa ilman merkittävää 
ionisupressiota. Tutkimuksen mukaan tekniikka soveltuu käytettäväksi normaalin 
APCI-ionilähteen lisäksi myös kuumasumutus-mikrosirulla, mikä mahdollistaa 
mikrofluidististen analyysitekniikoiden, kuten kapillaari-nestekromatografian, 
hyödyntämisen. Lisäksi tutkimuksessa kyettiin parantamaan nestefaasissa 
ionisoitumattomien steroidien ESI-ionisaatiota kemiallisella derivatisoinnilla sekä 
näytteenkäsittelyn saantoa pienen mittakaavan neste-neste uuton ja näytteen suoran 
injektion avulla. Edellä mainittuja tekniikoita yhdistämällä kehitettiin kolme uutta 
mittausmenetelmää, joiden käytännön suorituskyky arvioitiin validoinnilla sekä 
biologisten tutkimusnäytteiden analysoinnilla.  
 Väitöskirjatyön tulokset tarjoavat uusia, vaihtoehtoisia lähestymistapoja 
bioanalyyttisten LC–MS menetelmien kehitykseen. Kehitetyillä analyysimenetelmillä 
on huomattavia herkkyyteen, pitoisuusalueeseen sekä luotettavuuteen liittyviä etuja. 
Erityisesti ionisaatiotekniikoihin liittyvät tulokset sisältävät merkittävää uutta tietoa 
harvoin käytetyistä analyysitekniikoista. 
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 1 Introduction  
Quantitative analysis of small organic compounds in biological samples is an 
integral aspect of research in many fields, such as pharmaceutical development, 
clinical diagnosis, forensic and environmental toxicology, as well as in studying 
biological organisms. The analytes consist of different exogenous and endogenous 
compounds together with their metabolites, while the samples are usually different 
bodily fluids or tissues. Due to the complexity of the biological sample material and 
the often low sample volumes and analyte concentrations, highly selective and 
sensitive analytical methods are needed. Currently, the combination of 
chromatography and mass spectrometry is one of the most commonly used 
techniques. Although gas chromatography–mass spectrometry (GC–MS) has existed 
for decades (Ryhage, 1964), the amount of published work based on liquid 
chromatography–mass spectrometry (LC–MS) has increased rapidly, particularly 
during the last decade (Figure 1).  
 
 
Figure 1. The number of articles related to liquid chromatography–mass spectrometry. 
ISI Web of Knowledge, Thomson Reuters. Search string: Topic=("liquid 
chromatography–mass spectrometry") OR Topic=("lc-ms"). 
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The popularity of LC–MS is often attributed to its suitability for the analysis of polar 
compounds without derivatization, soft ionization conditions, fast chromatography, 
and the straightforward sample preparation techniques that can be used (Niessen, 
1999). However, despite the advantages of LC–MS, insufficient sensitivity, selectivity, 
or some other performance-related aspect often limits the use of these assays. 
Sensitivity and selectivity not only depend greatly on the mass spectrometer in use, 
but also on several other factors including sample preparation, type and conditions 
of the separation stage, and choice of ionization method.  
 Since the amount of analytes in biological samples is usually low, improving 
the sensitivity has long been one of the main objectives in developing new 
bioanalytical assays, being also a strong driving force in the introduction of new MS 
instruments. However, in addition to adequate sensitivity, a method has to be 
reliable and reproducible for its intended purpose. Moreover, depending on the 
purpose of the method, several other factors may need to be considered. As a 
summary, an ideal bioanalytical assay would be: 
 
 Sensitive enough for its intended purpose 
 Accurate and precise across the required concentration range  
 Robust in use 
 Fast 
 Easy to operate 
 Safe for its operators  
 Environmentally friendly 
 Economical 
 
In practice, it may be difficult to achieve all of these requirements in a single method. 
The work described in the present thesis concentrates on increasing the sensitivity of 
bioanalytical methods, but also addresses the above-mentioned factors that are 
related to the assay usability. The sensitivity issue is approached by exploiting 
different sample preparation techniques to maximize the analyte recovery (I, II, IV), 
together with new ionization techniques (II, III) and a derivatization method (IV) to 
improve the analyte recovery and response at the ionization stage. These two stages, 
sample preparation and ionization, were selected for their significance in the loss of 
analyte molecules during sample analysis.  
 Chapter 2 reviews the LC–MS instrumentation and bioanalytical methodology 
with an emphasis on sample preparation, ionization and quantification aspects. 
3 
 
 
Chapter 3 presents the specific challenges arising from low analyte amounts, 
dissecting an assay into stages where loss of analytes occurs and offering 
methodological solutions for the analyte preservation. Aims of the study are given in 
Chapter 4 and the experimental details in Chapter 5. The results are divided into 
three sections in Chapter 6, the first section discussing the sample preparation stage, 
the second describing the results achieved by modifying the ionization stage, and 
the third summarizing the developed assays. The overall results of the study are 
summarized and concluded in Chapter 7.      
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2 LC–MS in Quantitative Bioanalysis  
2.1 CHROMATOGRAPHIC SEPARATION 
High performance liquid chromatography (HPLC) has become a major analytical 
technique, particularly in the field of pharmaceutical and biomedical analysis (Unger 
et al., 2010; Görög, 2007). Despite the selectivity of the MS detection system, liquid 
separation is also a fundamental part of LC–MS assays for biological samples. The 
main reason for this is the complexity of the biological sample material. The 
presence of isobaric compounds is obvious, as is the possibility of similar product 
ions from the isobaric compounds. Without differences in the mass-to-charge (m/z) 
values either at MS or MSn levels, no mass spectrometric selectivity can be obtained. 
In addition, ionization enhancement or suppression due to coeluting sample 
components is also possible (Matuszewski et al., 1998; Matuszewski et al., 2003). If 
the compounds of interest are susceptible to this phenomenon, it can have a 
detrimental impact on assay sensitivity or reliability. Moreover, depending on the 
efforts made during sample pre-processing, the sample material can contaminate the 
ion source over time, although this can be avoided if selected chromatographic 
fractions can be diverted away from the mass spectrometer inlet.  
 
Chromatographic techniques 
In its modern form, the chromatographic separation of small organic compounds is 
most often performed with reversed phase (RP) columns (Majors, 2009). Since many 
analytes of biological activity are relatively polar, other forms of liquid 
chromatography can also be used, such as hydrophilic interaction chromatography 
(HILIC) (Alpert, 1990; Alpert, 2011), ion exchange chromatography, or techniques 
that utilize mixed column functionalities, such as reversed phase with embedded ion 
exchange capabilities (Nogueira at al., 2005; Ma et al., 2008). The dimensions of the 
chromatographic column used in LC–MS methods have been mostly dictated by 
different practical aspects such as the resolution needs and the mode of ionization in 
use. Electrospray ionization (ESI) is a concentration-sensitive process that benefits 
from the use of low eluent flow rates, which are best combined with sub-3 mm (i.d.) 
columns, while atmospheric pressure chemical ionization (APCI) and atmospheric 
pressure photoionization (APPI) are considered as mass-flow sensitive techniques 
that allow much higher flow rates and thus the use of wider column diameters 
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(Kebarle and Ho, 1997; Voyksner, 1997). However, since high assay sensitivity is 
usually desirable, column diameter can be also used to control the sample dilution 
within the column. For instance, decreasing the diameter may be used to increase 
the MS response obtained from a certain amount of analytes being injected, or to 
preserve the response when the injection volume is decreased. Small-diameter 
columns have several other attractive features, which were noticed very early in the 
development of HPLC; research on the miniaturization of the column dimensions 
was started already in the late 1960’s, with the first international meeting on 
microcolumn separation methods held in 1982 (Takeuchi, 1990). However, due to 
difficulties in the operation of the capillary LC systems and the limited detection 
techniques, columns with internal diameters between 2 and 5 mm have remained 
more popular in routine use. Recently there has been increasing interest in 
microfabricated devices and other microanalytical systems that can manipulate 
extremely small sample volumes. With these techniques, capillary- and microfluidic 
LC is usually employed to maintain sensitivity (Yin and Killeen, 2007; West et al., 
2008). 
 
Current status 
The development of LC column technology has been largely focused on RP columns, 
with silica as a major base material for the stationary phase, despite its limited pH 
stability (Unger et al., 2008). Monolith columns have been available for more than a 
decade, but despite the advantages of monoliths over particles, they have become 
overtaken by the recent advances in the particle technology (Majors, 2011). 
Decreasing the particle size, while maintaining the quality of the packing, has been 
an area of particular interest. The reason for the use of particles with sub-2 µm mean 
diameter in place of the previously utilized 3–5 µm can be seen from the following 
theoretical resolution equation (Snyder et al., 2010): 
 
     RS = (1/4) (α - 1) N1/2 {k/(1 + k)}    (1) 
 
where the retention factor k, selectivity α, and the number of theoretical plates N 
(column efficiency) contribute to the chromatographic separation. Since N is 
inversely proportional to particle diameter (Snyder et al., 2010), by decreasing the 
particle size by a factor of three, from 5 µm to 1.7 µm, N is also changed by three and 
the RS by the square root of three, or 1.7. As N is also inversely proportional to the 
square of the peak width (Snyder et al., 2010), the resulting narrower peaks improve 
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the separation, resulting also in higher peaks, as the peak area remains the same. 
Thus, in theory, the separation efficiency of a column that has certain internal 
dimensions can be improved by decreasing the particle size of the packing. 
Alternatively, the column can be shortened to achieve faster separations, without 
affecting the separation efficiency. The small particles can also offer greater 
flexibility in selecting the optimal mobile phase flow rate, which can be predicted 
using van Deemter calculations (van Deemter et al., 1956). The advantages of the 
described columns are obvious and their use has been rapidly increasing (Guillarme 
et al., 2010). However, one downside of the sub-2 µm particles is that the column 
backpressure ( p) increases at a greater rate than N when the particle size (dp) is 
decreased ( p 1/dp2) (Meyer, 2010). The resulting increase in the operational 
pressures has had an profound effect on the entire HPLC instrument development 
and to enable the efficient use of the new small-particle columns, systems capable of 
operating at and beyond 1000 bar (14000 psi) have been introduced (Nováková and 
Vlcková, 2009).  
 Despite the new generation of HPLC instruments, the full theoretical advances 
from the use of small particles are still not always realized (Fekete et al., 2010; 
Petersson et al., 2011) and the very high pressures and the increased susceptibility to 
plugging of the small-pore column frits have contributed to another field of column 
development: by using slightly bigger particles (2–3 µm) with a solid core and 
porous surface, several advantages, such as lower backpressures, can be realized 
without losing the improvements in separation efficiency (Abrahim et al., 2010; Oláh 
et al., 2010). Since 2011, these superficially porous particles have also been 
commercially available in 1.7 µm size and experimentally synthesized in even 
smaller diameters (Blue and Jorgenson, 2011). The porous surface layer of these 
particles can be as little as 0.1 µm, which provide a significantly lower diffusion path 
and higher rate of mass transfer in comparison to the fully porous particles of the 
same diameter.  
 
Liquid chromatography–Mass spectrometry 
Despite the recent improvements in the field, achieving the full potential of HPLC is 
limited in LC–MS due to specific needs associated with the two techniques, as noted 
by the pioneers of LC–MS already in 1975: “The chief problem at this time is that of 
achieving a useful balance between retaining the advantages of LC separation methods and 
accepting the requirement for vaporization of the solute” (Carroll et al., 1975). Certain 
mobile phase additives are usually required in the LC stage to achieve or improve 
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the separation, while at the ion source, the analyte molecules must be transferred 
from the condensed phase into the gas phase. The required phase-transfer 
necessitates the use of fully volatile eluents, precluding some of the most useful 
buffers, such as phosphate, that are commonly used to control analyte ionization in 
HPLC. It can be difficult to find substitutive volatile additives with adequate buffer 
capacity working in an appropriate pH range. In addition, many ion-pairing 
additives are problematic for MS ionization, particularly with ESI. It is well known 
that halogenated carboxyl acids, such as trifluoroacetic acid (TFA) and 
heptafluoroacetic acid (HFBA), usually produce severe ion suppression with ESI 
(Kuhlmann et al., 1995). Some ion pairing agents, such as triethylamine (TEA), are 
also known to strongly contaminate the MS instrument through surface adsorption, 
regardless of the ionization mode (Trufelli et al., 2011). In bioanalytical assays, high 
sensitivity is often required, and thus ion-pairing agents are usually avoided or used 
at low concentrations. 
 Sometimes the most efficient ionization is achieved with an eluent that is 
incompatible with the chromatography being employed. This is common with APPI 
that typically requires the use of a dopant solvent, which mediates the ionization 
process (Kauppila et al., 2002). Since the dopant cannot be added to the mobile phase 
without affecting the separation, it is infused post-column using a separate pump, 
which adds complexity to the instrumentation. 
 In some cases, derivatization is an efficient way to improve analyte ionization 
(Gao et al., 2005; Iwasaki et al., 2011). Particularly with ESI, this can be used to 
improve the gas-phase proton affinity of non-polar compounds (Higashi and 
Shimada, 2006; Liu et al., 2000). However, derivatization reactions can produce a 
variety of isomeric products from a single precursor that may be separated 
chromatographically, dividing the analyte response into separate chromatographic 
peaks, or otherwise complicating the separation (Kalhorn et al., 2007). 
2.2 ANALYTE IONIZATION 
As mentioned in the previous section, the early difficulties of combining LC and MS 
arose from the two instruments’ different requirements for the sample (Arpino, 1982). 
However, after several different approaches in combining LC and MS (Niessen, 
2006), the development of APCI (Horning et al., 1974a; Horning et al., 1974b; Carroll 
et al., 1975) and ESI (or ionspray) (Dole et al., 1968; Yamashita and Fenn, 1984a, 
Yamashita and Fenn, 1984b; Bruins et al., 1987; Fenn et al., 1989) has enabled the 
simple and efficient coupling of the instruments. In addition to the above methods, 
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many other ionization techniques and their modifications have been described later, 
but with the exception of APPI (Robb et al., 2000; Syage et al., 2000), they have 
remained marginal players and are not commercially available from the major MS 
instrument producers. In this section, the three most commonly employed 
techniques will be shortly presented.  
 
Electrospray ionization 
The basis of the ESI is the spraying of the mobile phase from the tip of a needle with 
the help of potential difference between the needle and the mass spectrometer inlet. 
The applied electric field leads to the formation of a Taylor cone at the needle tip 
(Taylor, 1964). The charged liquid escapes through the cone apex as small droplets, 
with charge imbalance generated by the electrical current applied to the needle. 
When the droplets shrink by evaporation, the charge density within the droplets 
increases. The increasing charge repulsion at the droplet surface finally exceeds the 
Rayleigh limit, leading to the formation of new droplets by Coulombic fission 
(Gomez and Tang, 1994). The process continues until all solvent molecules have 
been evaporated, or the droplet radius is sufficiently small to allow the charged 
analyte molecules to escape the droplet by field desorption. Modern ion sources 
employ heat and gas flow to assist the ESI process (Kebarle and Verkerk, 2009). 
 
Atmospheric pressure chemical ionization 
APCI is a chemical ionization process. The mobile phase is vaporized in the ion 
source with the help of heat and gas flow. A sharp needle with a high voltage is 
positioned in the forming gas cloud. A corona discharge at the needle tip generates 
high-energy ions from air, water, and solvents. Since the mobile phase is usually a 
mixture of water and an organic solvent, such as methanol or acetonitrile, the 
secondary chemical reagents are protonated or deprotonated ions of these solvents 
(e.g. H3O+ or OH-) that can react with the analytes, leading to analyte ionization 
(Carroll et al., 1981; Dzidic et al., 1974). 
 
Atmospheric pressure photoionization 
APPI is another form of chemical ionization that is based on similar ion source 
architecture as APCI. The main difference is that an ultraviolet (UV) lamp is used in 
place of a corona discharge needle. Most often, post-column infusion of suitable 
dopant solvent is employed. When the ionization energy of the dopant is sufficiently 
low, it can start the ionization process by absorbing photons generated by the UV 
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lamp. In the process, the formed dopant radical cation either loses a proton to the 
analyte with a higher proton affinity, or accepts an electron from a species with 
lower electron affinity, in which case the latter will be seen as a radical cation (Robb 
and Blades, 2006; Kauppila et al., 2002; Kauppila et al., 2004a; Robb et al., 2008; Robb 
and Blades, 2005).  
 
The suitability of these ionization techniques for the analysis of different compounds 
is often classified by their applicability to analytes with different polarities and 
molecular weights (Figure 2).  
 
           
 
Figure 2. Approximation for the suitability of ESI, APCI, and APPI ionization techniques 
for analytes with different polarity and molecule weight 
 
ESI is thought to be a softer ionization technique than APCI and APPI, being suitable 
for the analysis of macromolecules such as proteins (Mann et al., 1989). It also results 
in an efficient ionization of compounds with structures that can be ionized in 
solution, such as many drugs. However, ESI is associated with low mobile phase 
flow rates and stronger dependency on the eluent composition than APCI and APPI 
(Kostiainen and Kauppila, 2009), and is also more susceptible to matrix effects (ME) 
(Enke et al., 1997; Souverain et al., 2004a). For the ionization of non-polar 
compounds, APCI and APPI are more feasible and APPI in particular has been 
found to be superior for the analysis of non-polar compounds in complex biological 
matrices, such as endogenous steroids present at low concentrations (Harwood and 
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Handelsman, 2009). In an attempt to combine the advantages of the mentioned 
ionization techniques and to cover broader range of analytes, such as in non-
targeted metabolomic studies (Nordström et al., 2008), combinatory or multimode 
techniques (e.g. ESI and APCI or APPI in the same ion source) have also been 
developed (Gallagher et al., 2003; Short and Syage, 2008). Some of these multiple 
ionization techniques are commercially available from different MS manufacturers. 
 
Current use of different ionization techniques 
ESI continues to be the most widely used ionization technique. A search made in the 
Web of Science (ISI Web of Knowledge, Thomson Reuters) reveals the role of ESI in 
the field of LC–MS (Figure 3). The number of publications describing ESI–MS has 
continuously increased over the past 20 years, while APCI has remained as a 
complementary technique. APPI appears for the first time in the year 2000 (Robb et 
al., 2000; Syage et al., 2000) with 79 reports in 2010. Older techniques, such as 
thermospray ionization (TSI) (Blakley et al., 1980; Blakley and Vestal, 1983) have 
become obsolete at the turn of the millennia.  
  
 
Figure 3. The different ionization techniques referred to in the published articles during 
the last 20 years. ISI Web of Knowledge, Thomson Reuters. Representative search string: 
Topic=("electrospray ionization") OR Topic=("electrospray ionisation") AND 
Topic=("mass spectrometry"). 
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In addition to ESI, APCI, and APPI, several other atmospheric pressure ionization 
techniques or methods have been described in recent years. Many of these are based 
on the modifications or the unconventional use of existing ion sources, including 
sonic spray ionization (Hirabayashi et al., 1994), no-discharge APCI (Cristoni et al., 
2002), zero needle voltage ESI (Sørensen et al., 2008), photon independent ionization 
(Hommerson et al., 2007), atmospheric pressure laser ionization (Constapel et al., 
2005), and cold-spray ionization (Sakamoto et al., 2000). The majority of the 
mentioned techniques rely on the use of ESI, APCI, or APPI source, which however 
is operated only as a pneumatic nebulizer or thermal vaporizer, without applying 
any electrical potential, discharge, or photo irradiation for the generation of ions. 
Although these ionization techniques have some advantages over the more 
established counterparts, they have not generated widely implemented commercial 
solutions.  
 Some inherent drawbacks of ESI, mostly its susceptibility to ion suppression 
(Enke et al., 1997; King et al., 2000) and dependency on the flow rate have been 
reduced by the recent advances in ion source design. This has mainly been achieved 
by addition of heating capabilities and through the improvements in the use of 
drying and nebulizing gases (Ikonomou and Kebarle, 1994; Kebarle and Verkerk, 
2009). 
 The decrease in the dimensions of the chromatographic columns has created a 
need for smaller ion sources to reduce sample dilution after the separation stage. A 
number of techniques are described that combine ESI with microfluidic separations, 
often spraying directly from a capillary column (Koster and Verpoorte, 2007). ESI in 
itself has also some advantages when operated at very low flow rates and with small 
diameter electrospray emitters (Schmidt et al., 2003; Marginean et al., 2008), so the 
efforts in downscaling the dimensions of this ionization technique are not always 
dictated by the dimensions of the LC. The combination of an entire separation 
system and an ESI ion source within a single microchip has been available from 
Agilent Technologies since 2005. In addition, several different micro- and nano-ESI 
appliances also exist that can be used to improve the interfacing of LC and MS.  
 
Challenges related to ionization 
In bioanalytical method development, the choice of ionization technique is usually 
based on the nature of the analyte. For compounds that can be charged in solution, 
ESI is a straightforward choice, leaving APCI or APPI usually as a second alternative, 
often used for less polar analytes. However, in addition to the ionization capabilities 
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of the analyte, the sample matrix and the chromatographic conditions have an effect 
on the suitability of the ionization mode. As noted earlier, ESI is sensitive to the 
mobile phase constituents, flow rate, and the presence of matrix based compounds 
that co-elute with the analyte (Kostiainen and Kauppila, 2009). The pH of the mobile 
phase, for instance, has a strong effect on the ionization of cationic and anionic 
analytes. Furthermore, if the chromatographic separation necessitates the use of an 
ion pairing agent, such as TFA, to generate retention for polar cationic compounds, 
some degree of ion suppression is usually inevitable. This can also result from the 
co-elution of matrix compounds, often of an unknown nature. The actual 
mechanisms of ion suppression are debated, but in the case of ESI, it appears to be 
related to the processes taking place at the droplet surface (Enke et al., 1997). Since 
APCI and APPI do not involve any competition between analytes to enter the gas 
phase from the surface of the shrinking droplets, they can, in theory, produce a 
better analyte response in the presence of ion suppressing agents (Marchi et al., 2007; 
Souverain et al., 2004a). However, some compounds, quaternary ammonium ions 
being a good example, cannot be detected with APCI (Sakairi and Kato, 1998) or 
APPI (Robb and Blades, 2009; Syage et al., 2004), leaving ESI as the only choice, 
despite its limitations. 
 Derivatization has been particularly useful for the formation of [M]+, [M+H]+, or 
[M-H]- ions of compounds that are poorly ionized in their native form (Higashi and 
Shimada, 2006; Singh et al., 2000). However, it is usually avoided in the development 
of quantitative LC–MS assays, as it makes the sample preparation more laborious 
and is a potential source of measurement errors. 
 Lastly, as mentioned above, the use of capillary and nanoscale columns has 
created a demand for miniaturized ion sources. However, the majority of the 
compatible designs have been based solely on ESI, which has constrained the 
development of microscale LC–MS assays (Wood et al., 2003; Koster and Verpoorte, 
2007). Only recently, an experimental heated microchip nebulizer suitable for APCI 
and APPI ionization was described (Östman et al., 2004; Kauppila et al., 2004b), 
which triggered great interest in the development of microchip based ion sources 
that could be used for ionization techniques other than ESI (Sikanen et al., 2010).  
2.3 MASS SPECTROMETRIC DETECTION   
Within the mass spectrometer, analyte ions generated in the ion source are directed 
into a system that consists mainly of mass analyzers and a detector. The most widely 
used mass analyzers are quadrupole mass filters, different types of ion traps (IT) and 
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orbitraps, magnetic sectors, Fourier transform ion cyclotron resonance spectrometers 
(FT–ICR or FTMS), and time-of-flight (TOF) analyzers. Different hybrid instruments 
also exist, including quadrupole–quadrupole (or triple quadruple; QQQ), 
quadrupole–time-of-flight (Q–TOF), ion trap–time-of-flight (IT–TOF), time-of-flight–
time-of-flight (TOF–TOF), and different combinations of trap analyzers, such as 
quadrupole–ion trap (Q–Trap). When used for quantitative analysis in combination 
with LC, the type of MS is usually based on quadrupole, TOF, or IT analyzers. 
Depending on the intention of the analytical work, the mass analyzers’ different 
characteristics regarding sensitivity, scan speed, dynamic range, resolving power, 
mass accuracy, and mass range can be exploited. The highest possible mass accuracy, 
resolving power and the constant acquisition of spectra are seldom essential for 
quantitative bioanalysis, but sensitivity, dynamic range, and speed are important. 
These properties are usually considered best obtained with quadrupoles, certain IT 
analyzers, and hybrid instruments based on their combinations. However, whereas 
triple quadrupole technology is considered fairly mature (Bennett, 2011), recent 
instrument developments have improved the quantitative capabilities of other 
analyzers, particularly of the TOF-type, that now have a dynamic range of around 
four orders of magnitude, in addition to their inherently high speed and good 
resolving power (Williamson et al., 2008; Bristow et al,. 2008; Pelander et al., 2011; 
Fung et al., 2011). Moreover, as the quantitative performance of orbitrap based 
instruments approaches or even matches that of QQQ (Zhang et al., 2009; Kaufmann 
et al., 2011; Romero-González et al., 2011), the use of high resolution MS instruments 
is likely to become more wide-spread in quantitative bioanalysis (Ramanathan et al., 
2011). 
 Tandem mass spectrometry (MS/MS) is usually employed for increased analyte 
selectivity in quantitative bioanalysis. With QQQ instruments, this is achieved by 
operating the first quadrupole as an m/z selective filter, fragmenting the ions 
through collision-induced dissociations (CID) in the second quadrupole that acts as 
a collision cell, and transferring the product ions on to a third quadrupole that is 
used similarly to the first one (selected reaction monitoring or multiple reaction 
monitoring, SRM or MRM, respectively). Although the collision cells in the modern 
QQQ instruments may not be of quadrupole design, the instruments are still 
commonly known as “triple quadrupole”. MS/MS can also be performed with IT 
analyzers, but whereas QQQ instruments achieve MS/MS in space, an IT mass 
spectrometer performs MS/MS in time. This is achieved by injecting ions into a trap 
for a certain time, destabilizing the trap for all except the selected m/z ions, applying 
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molecule-fragmenting conditions and passing the formed ions out in a scanning 
function. These multiple steps usually limit the achievable scan speeds, making 
QQQ instruments more favorable for LC–MS use if fast data acquisition of 
numerous MS/MS transitions with maximum sensitivity is needed. However, 
especially the more recent linear quadrupole IT instruments (Douglas et al., 2005) 
can perform well in many quantitative applications requiring high sensitivity 
(Schwartz et al., 2002) and a CID process that is distinct from that of QQQ 
instruments, may also result in improved sensitivity (Shipkova et al., 2008). 
 
Notes on MS/MS detection 
Despite the compound selectivity available with the MS/MS technique, some 
detection-related challenges in bioanalytical LC–MS still remain. As noted earlier, 
isobaric compounds must have either chromatographic resolution or different 
product ions, in order to be separated. However, as a result of a cross-talk effect, 
selectivity issues can be experienced even if the compounds have different precursor 
ions. In QQQ instruments, this occurs when the dwell times of individual MS/MS 
transitions are short enough to enable the fragment ions from a previous transition 
to be monitored. The effect has particular importance with assays employing fast 
chromatography and numerous MS/MS transitions, as adequate cycle times can 
usually be obtained only by decreasing the dwell times of individual transitions 
(Tong et al., 1999). Developments in collision cell technology have reduced the 
possibility of cross-talk (Loboda et al., 2000), but it must be taken into account if very 
short dwell times are being used (Gergov et al., 2003). 
 Another issue affecting the use of MS/MS is related to the analysis of 
compounds with low proton affinities. Especially with ESI, the formation of different 
adducts, such as [M+Na]+ and [M+K]+, is sometimes favored over protonation of the 
analyte molecules. These adducts may be used for single ion monitoring (SIM) and 
their formation can be even promoted by using different mobile phase additives. 
However, these adducts are generally not considered suitable as precursors for 
MS/MS, since structurally relevant fragment ions may not be produced in the CID 
process of the alkali-metal adducts of non-ionizable compounds due to the 
dissociation of the complexes to bare alkali-metal ions (Maleknia and Brodbelt, 1992). 
Some adducts however, such as lithium adduct of vitamin D, are reported to be 
sufficiently stable for quantitative MS/MS (Casetta et al., 2010; Yuan et al., 2011).  
 Finally, with MS/MS, the fragmentation characteristics of the analyte and the 
number of different product ions resulting from the dissociation of the precursor ion 
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are reflected on the limits of detection and quantification of an assay – distribution of 
the charge to a great number of different product ions leads to difficulties in 
selecting a single high-intensity product ion. However, the overall sensitivity of the 
LC–MS/MS assay depends also to a great extent on the MS instrument in use.  
2.4 SAMPLE PREPARATION TECHNIQUES  
A search made in Web of Science for different sample matrices using the words 
"liquid chromatography-mass spectrometry" as a publication topic reveals the 
significance of blood sample analysis (usually in form of plasma and serum) in 
bioanalytical research (Figure 4).  
   
 
Figure 4. Occurrence of some commonly analyzed biological sample matrices in the 
articles associated with LC–MS during the years 2006–2010. ISI Web of Knowledge, 
Thomson Reuters. Representative search string: Topic=("liquid chromatography–mass 
spectrometry") AND Topic=("plasma").  
 
However, even if sample preparation is a potential source of measurement errors 
(Skonberg et al., 2010), direct injection of plasma, serum, or some other commonly 
analyzed sample matrix into the separation column is rarely feasible. Even if most 
sample types are aqueous in nature, they usually contain material that will not be 
dissolved in the mobile phase and thus can obstruct the chromatographic column. 
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The sample may also contain ion-pairing substances that change the retention 
behavior of the column by accumulating in the stationary phase. Depending on the 
ionization technique employed, MS detection is also sensitive to ion suppression, for 
example due to phospholipids, nonvolatile material, different extractables from 
plastics, and other sample-related, often unknown, factors (Souverain et al., 2004a). 
In addition to ion suppression, any non-volatile material in the sample solution will 
accumulate on the ion source surfaces. Moreover, despite the combined selectivity of 
chromatography and MS, in some cases, the sample may need additional 
fractionation before the LC–MS analysis.  
 
Current use of different sample preparation techniques 
There are several different sample preparation techniques (Kole et al., 2011). For the 
LC–MS analysis of drugs and endogenous compounds, the main objective is 
removal of the abundant proteins. The protein content in biological matrices is high; 
in human serum, for instance, the normal albumin concentration is around 3–5 
grams per 100 ml (Rustad et al., 2004). However, even after the protein removal, 
additional clean-up may be needed, depending on the sample and the LC–MS 
instrumentation in use. To gain some insight into the current use of different 
methods, 21 recent issues of the Journal of Chromatography B and the Journal of 
Pharmaceutical and Biomedical Analysis were reviewed. In these issues, 141 LC–MS 
assays for human or animal samples were presented (Table 1).   
  
Table 1. Current use of different sample preparation techniques. Number of times 
described in 21 recent issues of J Chromatogr B (Volume 878, issues 15–25) and J 
Pharm Biomed Anal (Volumes 51–52). 
 
Sample matrix PPT LLE SPE 
Direct 
injection 
Other 
Plasma 43 32 18 0 4 
Urine 4 3 6 1 0 
Tissue 6 2 3 0 0 
Feces 3 2 0 0 0 
Serum 1 2 2 0 0 
Whole blood 2 1 1 0 0 
CSF 0 0 1 1 1 
Microdialysate 0 0 0 1 1 
Total 59 42 31 3 6 
               PPT: protein precipitation 
               LLE: liquid-liquid extraction 
               SPE: solid phase extraction 
18 
 
 
Of all the described methods, the vast majority were employing protein precipitation 
(PPT) with miscible organic solvents, liquid-liquid extraction (LLE) with immiscible 
organic solvents, or solid phase extraction (SPE) with various stationary phases. 
Only three methods described direct injection of samples without any pre-
treatments. The number of sample preparation techniques other than PPT, LLE, and 
SPE was less than 5 percent. These techniques included solid phase microextraction 
(SPME) (Arthur and Pawliszyn, 1990), stir-bar sorptive extraction (SBSE) (Baltussen 
et al., 1999) matrix solid phase dispersion (MSPD) (Long et al., 1990) and the use of 
an on-line column based on restricted access media (RAM) (Hagestam and 
Pinkerton, 1985; Šatínský and Solich, 2007). 
 Although not present in the reviewed articles, several additional sample 
preparation techniques such as microextraction in packed syringe (MEPS) (Abdel-
Rehim, 2004) and liquid phase microextraction (LPME) (Jinno et al., 1996) are 
available. A significant new addition to the repertoire of commercially available 
sample preparation products is an SPE-type cartridge that combines PPT with 
specific removal of the ion-suppressing phospholipids (Pucci et al., 2009). However, 
despite these new techniques, LLE, PPT, and SPE have retained their popularity, 
most probably due to their simplicity. In particular, PPT and LLE are 
straightforward procedures that can be performed in basic test tubes or centrifuge 
tubes (Figure 5). They are also relatively easy to scale down, and performing PPT or 
LLE well plates has gained popularity. Even though usually relying on the use of 
commercial supplies, SPE can offer more variability in analyte selectivity due to the 
great number of different packings currently available.  
 
Challenges related to sample preparation 
Despite their popularity, LLE, PPT, and SPE all retain some negative aspects. 
Samples that are prepared with PPT are typically associated with stronger ME than 
those made using LLE and SPE (Souverain et al., 2004a). This is significant, as PPT 
and the ion-suppression prone ESI are the two most widely used techniques. With 
LLE, high recoveries cannot be realized for hydrophilic compounds, as the 
extraction process is based on the use of solvents that are immiscible with the 
aqueous sample media. SPE is an efficient technique, but the method development 
can be time consuming, especially if the physicochemical properties of the analytes 
are diverse (Marchi et al., 2009). Moreover, all these techniques are usually 
performed off-line, which limits the sample throughput. Instruments for automated 
sample preparation are available and there is increasing interest in on-line 
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Transfer sample into a 
test tube 
Remove the precipitate 
by filtration or 
centrifugation 
Add solvent and mix 
Dilute the filtrate/ 
supernatant if needed 
Transfer sample into a 
test tube 
Add solvent and mix 
Separate the two 
phases; collect the 
solvent into another 
tube 
Evaporate to dryness 
Transfer to sample vial, 
inject for analysis 
Condition an SPE 
cartridge 
Transfer sample into the 
cartridge 
Wash out unwanted 
sample components 
with suitable solution 
Elute the analytes with 
a suitable solution 
Dilute the solution if 
needed 
Reconstitute in mobile 
phase 
techniques (Mitchell et al., 2010). However, as evidenced by Table 1, this interest has 
not yet challenged the popularity of the traditional techniques, as only four of the 
141 presented methods employ on-line sample preparation. 
 
         Protein precipitation           Liquid-liquid extraction        Solid phase extraction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Principles of the three most commonly used sample preparation techniques 
 
Lastly, in addition to influencing the throughput, clean-up efficiency, recovery, and 
precision of the method, the sample preparation technique contributes significantly 
to the total cost and environmental impact of the analyses. In the ideal case, the 
biological sample would be injected as such, without a separate sample preparation 
stage. Certain commercial instruments are available that do achieve this possibility, 
incorporating on-line SPE or RAM in the analytical instrumentation (Souverain et al., 
2004b). For a bioanalytical laboratory, this is an attractive approach, but its 
implementation requires considerable investments, compared to the traditional 
methods.  
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2.5 QUANTIFICATION, VALIDATION, AND RELIABILITY OF 
RESULTS 
A bioanalytical LC–MS assay is built on the same principles as a typical quantitative 
HPLC method. Chromatographic peak areas are usually taken as the index of 
analyte response and the concentrations of the unknowns are determined by using 
the response-concentration equation of the calibration curve. Due to the complexity 
of biological matrices, the calibration standards are usually prepared by adding the 
analyte to a blank matrix and processing it similarly to the so-called incurred 
samples (samples taken from human or animal subject after administration of the 
analyte). To compensate for the variable loss of analyte in the different stages of 
sample preparation and analysis, internal standards (IS) are often employed. In this 
case, peak area ratios of the analyte to the IS are calculated as a function of the 
concentration of the analyte. 
 
Assay validation  
In addition to the technical aspects of a LC–MS assay, it must fulfill its intended 
purpose, which is usually the sufficiently accurate determination of the analyte 
concentration in a sample with long-term reproducibility. Exactly what is sufficient 
is dictated by the intended purpose for which the results will be used (Lee et al., 
2006). According to the International Organization for Standardization (ISO), method 
validation is required to “confirm the fitness for the purpose of an analytical method.” 
This is to verify that the “defined method protocol, applicable to a specified type of test 
material and to a defined concentration range of the analyte is fit for a particular analytical 
purpose” (ISO/IEC 17025:2005). Demonstrating the validity of bioanalytical assays is 
not a trivial task and it has been the subject of much debate over the past 15 years. 
As a result, there are now reasonably well-established principles for the validation, 
with different authorities, having slightly different guidelines for the method 
validation, governing many analytical laboratories (European Commission, 2002; 
Torbeck, 2002). However, guidance by the U.S Food and Drug Administration (FDA) 
on bioanalytical method validation (FDA, 2001) with supplemental material from the 
3rd AAPS/FDA Bioanalytical Workshop (Viswanathan et al., 2007), has been of 
particular value to practitioners of quantitative bioanalytical LC–MS, especially for 
drug analysis. The FDA guidance covers the following aspects of method validation:  
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Construction of the calibration/standard curve 
 Qualities of the calibration samples 
 Amount of concentration levels and blanks 
 Criteria for the lowest standard of the calibration curve 
 Requirements for the concentration-response curve 
 
Selectivity 
 Lack of interference from biological matrix; matrix effect should not 
compromise method performance  
 
Determination of accuracy, precision, and recovery 
 Analysis of multiple spiked samples across the expected range 
 Criteria for the variability of the measurement results  
 Criteria for the closeness of the measured and calculated concentrations  
 Requirements for the analyte recovery during sample preparation  
 
Instructions for studying analyte stability  
 Long term storage stability  
 Stability during multiple freeze and thaw cycles 
 Short-term stability after thawing 
 Stability after sample preparation 
 Stability of the standard and IS stock solutions 
 
In addition, it sets recommendations for the application of the method for routine 
analysis. However, the guidance is not a comprehensive collection of all relevant 
issues that must be taken into account when the validity of the measurement is of 
concern. It is also intended solely for the drug analysis and cannot be directly 
applied for the analysis of endogenous compounds. 
 
Quantitative bioanalysis  
The prevailing practice of comparing the instrument response between spiked and 
incurred samples involves the assumption that the analyte is extracted similarly 
from both samples. However, depending on the sample material, the analyte may be 
distributed in the samples differently, for example due to the different nature of 
protein binding. The determination of method accuracy according to FDA may not 
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fully reveal this, being determined by analyzing spiked matrix against a calibration 
curve of spiked matrix. 
 For endogenous analytes, the accurate quantification is more complicated. As 
an analyte-free sample matrix is usually not available, alternative strategies for 
calibration have to be used. Two techniques exist: the spiking of surrogate matrix 
with authentic analyte, or spiking of authentic, analyte-containing matrix with 
surrogate analyte (van de Merbel, 2008). The first approach assumes that the 
solubility and extractability from the surrogate matrix is comparable to the sample 
matrix. The second assumes that the physicochemical properties of the surrogate 
analyte are identical to the analyte of interest. For this, stable isotope labeled 
analogues are usually employed (Petucci et al., 2010). 
 
Matrix effects and quantification of low concentrations 
Ion suppression can prevent the analysis of compounds for which there is a low 
response, but in many cases, the sensitivity of the assay can be adequate despite the 
presence of ME. However, the variability in the quantity of ME between samples 
and species leads to the variability in analytical results if adequate IS is not used. 
There is debate whether matrix matching is necessary or if surrogate standards are 
acceptable when isotope labeled IS is used (Jacobson et al., 2011, Hewavitharana, 
2011). Despite its positive effect on accuracy, the use of IS cannot compensate for the 
loss of detector response due to ion suppression.  
 Quantification at the sensitivity limits of the method has been addressed in the 
FDA guideline by setting several requirements for the lowest concentration level of 
the calibration curve (lower limit of quantification, LLOQ). With these conditions, 
higher LLOQ concentrations are usually obtained in comparison to the values based 
on S/N ratios or response linearity (ICH, 2005). However, when constructing a 
calibration curve for bioanalysis using standards in a surrogate matrix, even the 
FDA-defined LLOQ can represent an overestimate. This is due to the need to use the 
surrogate matrix for both standards and the samples that are used for the estimation 
of LLOQ. If surrogate standards are employed, the absolute response from a 
standard at LLOQ has to be reasonably strong to leave some headroom for the 
possible ion suppression in the samples at the same concentration level. Otherwise, 
false negative results will be reported if ion suppression is strong enough to 
diminish the analyte response below the detection limit. In addition, the RSD values 
gathered from the analysis of samples in surrogate matrix at LLOQ can overestimate 
the method precision for analyzing biological samples at the same concentration 
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level. For this reason, when using surrogate standards for biological samples at 
LLOQ levels, lack of ME should be assured, or its actual percentage amount should 
be determined (Viswanathan et al., 2007), and its effect on the results taken into 
consideration.  
 There is also a selectivity-related issue in the LC–MS analysis of samples near 
to the LLOQ. A common practice to increase the confidence of the analyte 
identification is to monitor a second, qualifier MS/MS transition in addition to that 
being used for quantification. A branching ratio of the precursor ion fragmentation 
to the qualifier and quantifier ions is usually used as an acceptance criterion for the 
identification (Kushnir et al., 2006). However, if the qualifier ion response is lower 
than that of the quantifier, the qualifier signal may be absent at the LLOQ.  
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3 Towards maximum assay sensitivity 
Despite the low amount or poor ionization of the analytes, injection of the sample 
has to result in an adequate detector response to enable successful quantification. As 
reviewed in the previous sections, the detector response is related to the employed 
ionization technique, the type of mass spectrometer in use, and the dimensions and 
operational conditions of the chromatographic separation. Furthermore, the sample 
preparation can have a strong effect on the response, determining the recovery of the 
analyte and the amount of possible ion suppression, sometimes described as 
“process efficiency” of the sample preparation (Matuszewski et al., 2003).  
 In this study, before setting the aims and objectives for the method 
development, all of the above-mentioned aspects that contribute to the LC–MS/MS 
assay sensitivity were considered. As a result, the following list of conditions was 
compiled, which summarizes the theoretical criteria for achieving maximum 
detector response: 
 
1. All available sample material is used 
2. All analyte molecules are recovered during the sample preparation process 
3. All of the prepared sample is injected 
4. Chromatographic peak volume is infinitesimally small 
5. All the analyte molecules are ionized to a single form of ions that enter the gas 
phase and remain ionized 
6. All the analyte ions are taken into the MS – simultaneously 
7. If tandem mass spectrometry is being used, the amount of monitored product 
ions is equal to the number of precursor ions 
8. All of the analyte ions are preserved during the transfer, focusing, selection, 
and fragmentation within the MS  
9. Every analyte ion contributes to the mass spectrometric signal; the detector 
has an unlimited dynamic range  
10. The instrument creates noiseless data 
 
In reality, few of the above conditions can be realized. In particular, the loss of 
analyte ions during the MS stage is largely related to the MS instrument design, and 
thus out of the control of the analyst. However, some stages before the MS analysis 
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are critical for preserving the analyte and preventing the sample dilution. Sample 
preparation should be performed using techniques that cause a minimum amount of 
analyte loss. If the sample size is significantly larger than the injection volume used 
for the method, sample preparation may be used to concentrate the analyte in the 
injection solvent. Further concentration can usually be made in the column head 
using gradient elution, before the chromatographic separation. During the 
separation, minimal peak volumes should be generated by employing suitable 
chromatography and downscaling of the internal volumes of the column and the 
connections. The most efficient ionization technique and ion source conditions 
should be used. Analyte structure may be manipulated to improve its ionization 
properties. If possible, the dimensions and positioning of the ion source should be 
optimized to minimize sample dilution and analyte loss during the ionization 
process, which is particularly important if very low flow rates are used in 
conjunction with capillary columns.  
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4 Aims of the study 
The aim of this study was to develop new approaches to overcome three major 
sensitivity-limiting factors of bioanalytical LC–MS assays: low analyte 
concentrations, small sample volumes, and poor ionization. The work was focused 
on sample preparation and ionization. Overall, the aim was to combine different 
techniques and demonstrate their feasibility by developing complete, validated 
assays that were applied for routine sample analysis. The following cases were 
selected for the experimental work: 
 
 Quantitative analysis of α1-adrenoceptor antagonist drug, tamsulosin, in human 
serum and 30 µl of aqueous humor (AH). The objective was to maximize the analyte 
recovery during the sample preparation and enable the analysis of AH and serum 
samples within a single analytical sequence (I). 
 
 Quantitative analysis of the neurotransmitter acetylcholine in 15 µl of rat brain 
microdialysate. The objective was to achieve efficient analyte ionization, despite the 
presence of an ion-suppressing mobile phase, and maximum analyte recovery 
during the sample preparation (II). 
 
 Miniaturization of the atmospheric pressure thermospray ionization technique 
(APTSI) that was employed in the second case. The objective was to study the 
feasibility of the technique for use with microscale separation systems using a novel 
microchip nebulizer (III).  
 
 Simultaneous analysis of seven endogenic steroids in 150 µl of human serum. The 
objective was to improve the analyte ionization through derivatization, and to 
achieve maximum analyte recovery during sample preparation (IV).  
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5 Experimental 
5.1 INSTRUMENTS AND SUPPLIES 
The analytical instruments and other supplies used for the study are listed in    
Table 2.  
 
Table 2. A list of instruments and supplies  
 
HPLC and MS Manufacturer Paper 
Thermo LTQ linear ion trap (ESI, APCI)  Thermo Scientific (San Jose, CA, USA) I, II, III 
Agilent 6410 Triple Quadrupole (ESI)  Agilent Technologies (Palo Alto, CA, USA) IV 
Microchip-APCI Custom, described in the paper III 
ADPC-IMS PicoFrit ion source adapter New Objective Inc. (Woburn, MA, USA) III 
Surveyor HPLC system  Thermo Scientific I, II, III 
Agilent 1200 Series RRLC  Agilent Technologies IV 
Xcalibur 1.4 SR1 Acquisition software Thermo Scientific I, II, III 
LCquan 2.0 Quantification software Thermo Scientific I, II 
MassHunter Acquisition software B.01.04  Agilent Technologies IV 
Quantitative Analysis software B.04.00 Agilent Technologies IV 
   
HPLC columns Manufacturer Paper 
Zorbax SB-C18 (50×2.1 mm; 1.8 µm) Agilent Technologies IV 
Zorbax SB-Aq (100×2.1 mm; 3.5 µm)  Agilent Technologies II 
Zorbax XDB-C8 Guard Column  Agilent Technologies I 
Zorbax SB-Aq Guard Column  Agilent Technologies II 
Atlantis HILIC Silica (50×2.1 mm; 3 µm) Waters (Milford, MA, USA) II 
Oasis WCX (20×2.1 mm; 30 µm) Waters II 
Waters XTerra C8 (50 2.1 mm; 3.5 µm) Waters I 
polyHYDROXYETHYL A (100×2.1 mm; 5 µm) PolyLC (Columbia, MD, USA) II 
   
General supplies Manufacturer Paper 
Water purification system, Milli-Q Gradient  Millipore (Milford, MA, USA) All 
DC power supply, Iso-Tech IPS-603  RS Components (Northants, England) III 
Analytical balance, AX205  
Mass flow controller, Aalborg GFC-17   
 
Mettler-Toledo (Greifensee, Switzerland) 
Aalborg Instruments & Controls, Inc., 
Orangeburg, NY, USA 
All 
Test tube shaker, Multi Reax  Heidolph (Schwabach, Germany) IV 
Laboratory oven, ULE500  Memmert (Schwabach, Germany) IV 
Nitrogen evaporator, N-EVAP 112  Organomation Assoc. (Berlin, MA, USA) IV 
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Mass spectrometer tuning and calibration 
The mass spectrometer used in papers I, II, and III (Thermo LTQ) was tuned by 
infusing the analyzed compounds and employing the semi-automatic tuning 
function of the instrument software. The same tuning was used in papers II and III. 
The mass spectrometer used in paper IV (Agilent G6410A) was calibrated and tuned 
by using the instrument built-in automatic tuning function and the associated 
tuning solution.   
5.2 CHEMICALS AND REAGENTS 
The chemicals and reagents used in the work are listed in Table 3. The analyzed 
compounds are presented in Figure 6.  
 
Table 3. A list of analytical instruments and supplies  
 
Chemicals Manufacturer/Supplier Paper 
17α-hydroxypregnenolone  Sigma-Aldrich Chemie (Steinheim, Germany) IV 
17α-hydroxyprogesterone  Sigma-Aldrich Chemie  IV 
2,2′-bipyridyl  Sigma-Aldrich Chemie  III 
6-ketocholestanol Sigma-Aldrich Chemie III 
Acetonitrile, HPLC Ultra Gradient Mallinckrodt Baker (Deventer, Netherlands) II, III 
Acetonitrile, HPLC-grade  Rathburn (Walkerburn, UK) I 
Acetylcholine iodide Fluka (Buchs, Switzerland) II, III 
Acetyl-β-methylcholine Sigma-Aldrich Chemie  III 
Aldosterone Sigma-Aldrich Chemie  IV 
Ammonium acetate Sigma-Aldrich Chemie  III 
Ammonium formate Sigma-Aldrich Chemie  III 
Ammonium hydroxide solution  Sigma-Aldrich Chemie  III 
Androstanedione  Steraloids (Newport, RI, USA) IV 
Androstenedione  Sigma-Aldrich Chemie  IV 
Androsterone Sigma-Aldrich Chemie  IV 
Angiotensin I Sigma-Aldrich Chemie  III 
Arginine Sigma-Aldrich Chemie  III 
Bovine serum albumin (BSA) Sigma-Aldrich Chemie  IV 
Calcium chloride  Merck (Darmstadt, Germany) II 
Choline chloride Fluka (Buchs, Switzerland)  II, III 
D3-17α-hydroxypregnenolone  C/D/N Isotopes (Quebec, Canada) IV 
D3-testosterone Sigma-Aldrich Chemie  IV 
D4-pregnenolone  C/D/N Isotopes  IV 
D6-dehydroepiandrosterone  Sigma-Aldrich Chemie  IV 
D7-androstenedione  Steraloids  IV 
D8-17α-hydroxyprogesterone  C/D/N Isotopes  IV 
D9-acetylcholine chloride C/D/N isotopes  II 
D9-progesterone  Steraloids  IV 
Dehydroepiandrosterone Sigma-Aldrich Chemie  IV 
   
            (Table continues to the following page) 
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(Table continued from the previous page) 
 
 
Chemicals Manufacturer/Supplier Paper 
Dihydrotestosterone Steraloids  IV 
Estradiol Sigma-Aldrich Chemie  IV 
Estrone  Sigma-Aldrich Chemie  IV 
Ethyl acetate  LabScan (Dublin, Ireland) I 
Etiocholanolone Gift from United Medix Laboratories Ltd. IV 
Formic acid Sigma-Aldrich Chemie  I, III 
Formic acid, LC/MS grade Sigma-Aldrich Chemie  IV 
Glucose Sigma-Aldrich Chemie  III 
Heptafluorobutyric acid (HFBA)  Fluka II 
Hydroxylamine hydrochloride Sigma-Aldrich Chemie  IV 
Iron (II) sulphate  Sigma-Aldrich Chemie  III 
Labetalol hydrochloride  Sigma-Aldrich Chemie  I 
Lidocaine Sigma-Aldrich Chemie  III 
Magnesium chloride  Riedel-de Haën (Seelze, Germany) II 
Methanol, HPLC Gradient Grade Mallinckrodt Baker  III 
Methanol, LC/MS grade Sigma-Aldrich Chemie  IV 
Methyl tert-butyl ether (MTBE) Sigma-Aldrich Chemie  IV 
Neostigmine bromide  Sigma-Aldrich Chemie  II 
Nitrogen, pharmacopeial grade  Oy AGA Ab (Espoo, Finland)  III 
Ofloxacin Sigma-Aldrich Chemie  III 
Phenylalanine amide  Sigma-Aldrich Chemie  III 
Potassium chloride  Merck  II 
Pregnenolone  Sigma-Aldrich Chemie  IV 
Progesterone  Steraloids  IV 
Sodium bicarbonate  Riedel-de Haën I 
Sodium chloride Mallinckrodt Baker II 
Sterofundin ISO  B.Braun (Melsungen, Germany) IV 
Tamsulosin hydrochloride  Fermion Oy (Espoo, Finland) I 
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Figure 6. Structures and monoisotopic masses of compounds used in the study. Isotope 
labeled internal standards are not included. Numbering of the steroid carbons and the 
derivatization reaction (IV) are presented using DHEA. 
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(Figure continued from the previous page) 
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Figure 6. Continued 
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6 Results and discussion 
This chapter is divided into three sections. In the first section (6.1), results of the 
sample preparation stage of the developed assays are presented and discussed. The 
second section (6.2) concentrates on the ionization stage. In the third section (6.3), the 
developed assays are summarized and the contribution of the chosen approaches to 
the assay performance and usability are critically assessed. The papers are referred 
to by their Roman numerals. 
6.1 INCREASING THE ANALYTE RECOVERY 
Particularly with small-volume samples, a significant percentage of the analytes may 
be lost during the various steps of the sample preparation process. The term 
“analyte recovery” is used here to describe the percentage fraction of analytes in the 
initial sample that were preserved during the sample preparation and injected into 
the column. In each case of this study, the challenges in realizing maximum analyte 
recovery were different: ionizable analyte of medium polarity in an aqueous 
biological matrix (I), permanently ionized polar analyte in aqueous dialysis fluid (II), 
and non-ionizable, non-polar analytes in serum (IV) (Figure 6). The results 
demonstrate how analyte polarity can govern the later stages of an assay, including 
the chromatographic technique, injection volume, and ionization.    
 
6.1.1  Direct sample injection (I, II) 
In the analysis of tamsulosin, the objective was to prevent unnecessary analyte loss 
by keeping the sample preparation steps at minimum. AH is derived from plasma 
within the ciliary body of the eye, containing primarily the substrates and by-
products of the metabolic processes of the vascular cornea and the lens (Goel et al., 
2010). The protein content of human AH is minimal, between 0.12 and 0.50 mg/mL 
(Chowdhury et al., 2010). Since this is around 150−600 times less than in human 
serum (Rustad et al., 2004), the typical sample preparation methods (PPT, LLE, SPE) 
were not considered necessary for protein removal. It was also found that the 
aqueous tamsulosin solution could be injected in high volumes using the developed 
chromatographic method. Hence, direct injection of AH, subsequent to the IS 
addition, was employed. A pre-column was included and provided sufficient 
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protection against possible protein precipitation on the column head. The maximum 
amount of AH that could be accurately pipetted from all the sample tubes was 30 µl. 
After adding the IS, the total volume was 50 µl, of which 35 µl could be injected. A 
larger injection volume would have been desirable, but the lack of precision in the 
autosampler needle height setting prevented injecting the entire sample. By using 
special vials with a spring between the vial and the insert, higher sample recoveries 
would have been attainable. However, since the sample was prepared directly in an 
insert without any extraction steps, relatively high analyte recovery (70%) was 
obtained even with the more economical standard vials and inserts.   
 Direct injection of the sample was also used for the analysis of ACh. However, 
the assay development was not as straightforward as with tamsulosin, mainly due to 
the very high polarity of the analyte. With RP columns, ion-pair reagents were 
needed to generate sufficient retention, but the resulting mobile phase was 
unfavorable for ESI ionization, both because of the ion-pair additives and the low 
amount of organic solvent that had to be used (2% acetonitrile). APCI could not be 
employed, since ACh was not detectable with this technique. Therefore, an attempt 
was made to use HILIC, which employs a mobile phase with better compatibility 
with ESI. With HILIC, adequate retention was achieved for ACh, but the retention of 
the inorganic salts of the microdialysate buffer affected the chromatographic 
selectivity. Attempts to remove these salts and to concentrate the sample with a 
short on-line cation exchange column failed, most probably due to the strong salt 
concentration of the dialysate sample. In addition, the use of HILIC required heavy 
dilution of the microdialysate with acetonitrile to decrease the elution strength of the 
injected solution, ruling out direct injection of the samples. Fortunately, ACh was 
found to produce intense MS response when APCI source was used without the 
corona needle, even if TFA was included in the mobile phase. The accidental 
discovery of this special ionization technique, which will be discussed in more detail 
in the next chapter, allowed the use of reversed phase separation with TFA and the 
direct injection technique. 
 For the same reasons encountered with the tamsulosin assay, the microdialysis 
sample was prepared by pipette-mixing the sample and the IS in a pulled-point vial 
insert (Figure 7). Due to the high sampling frequency of the microdialysis 
experiment, dialysate fractions of only around 20 µl were collected. Of these samples, 
15 µl could be transferred to the vials and used for the analysis. After adding equal 
volume of aqueous IS solution to the sample (bringing the total volume to 30 µl), 20 
µl was injected. Using this method, analyte recovery of 67% was achieved (20 µl 
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injection of a 30 µl sample). Larger injection volumes could not be employed without 
disturbing the chromatography, which was based on isocratic elution with a mobile 
phase containing only 2% acetonitrile. For this reason, the maximum amount of 
microdialysate was used and the total sample volume after IS addition was kept as 
low as practical. 
 
 
 
Figure 7. Sample solution levels at the pulled-point vial inserts used for the direct 
injection analyses (I, II). Left: 30 µL (15 µL of microdialysate, 15 µL of internal 
standard), of which 20 was injected. Right: 50 µL (35 µL of aqueous humor, 15 µL of 
internal standard), of which 35 µL was injected. In the photograph, colored water was 
used for illustrative purposes instead of real samples. 
 
Based on the described studies, direct injection of small-volume samples with IS 
dilution was shown to be an efficient way of delivering the maximum amount of 
analytes into the column and should be used when sample pre-processing is not 
absolutely necessary. Since it does not involve any extraction steps or transfers of the 
sample, analyte recovery is theoretically the ratio of injection volume to volume of 
the sample in the vial. In addition, variability in the extraction recovery and the 
possible measurement errors arising from the multiple pre-processing steps are 
avoided.  
 However, direct injection is limited to samples that are relatively free from 
protein or particulate material that can obstruct the column. It is also necessary to 
resolve any possible matrix effects during subsequent stages of an assay. In addition, 
the sample volume has to be within the injection volume limits of the autosampler. 
Depending on the sample composition, large injection volumes may also overload 
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the separation column, resulting in poor chromatography. This has to be considered 
during the selection of the column dimensions and type; the new superficially 
porous particles for instance have a lower mass loading capacity in comparison with 
the fully porous ones. Moreover, the amount of sample that is left in the vial after 
injection depends on the design of the vial and the instrument. In both discussed 
studies, pulled-point vial inserts were used to maintain a high solution surface level 
(Figure 6), but since the employed autosampler was not able to withdraw the sample 
from the very bottom of the vials, some loss of sample solution was inevitable.  
 
6.1.2  Sample concentration and recovery maximization (IV) 
Concentrating the samples during the sample preparation process has been 
mentioned as a means to increase the analyte recovery. This technique was applied 
in the human serum steroid assay. Direct injection of serum is not feasible and hence 
a different technique had to be employed. However, the aim was to maintain the 
sample preparation as simple and robust as possible, while ensuring efficient clean-
up. In addition, analyte derivatization was known to be necessary and its suitability 
for integration with the sample preparation was taken into account.  
 Protein precipitation with organic solvent was not considered, as the technique 
leads to large volumes of partly aqueous solution, which cannot be easily 
concentrated by evaporation. Moreover, PPT has been shown to be more susceptible 
to ion suppression than some other popular techniques, like SPE and LLE. After 
experimenting with LLE, it was found to produce high extracting recoveries when 
diethyl ether or MTBE were used. These volatile organic solvents could also be 
rapidly evaporated. However, since a typical LLE process involves the transfer of 
the sample from the evaporation tube into the injection vial or well, the resulting 
analyte loss can be significant, particularly if the volume of the reconstituted sample 
is small. To ensure maximum analyte recovery during the LLE, a simplified method 
was developed: the sample extraction, evaporation, derivatization, and injection 
were performed using only two autosampler vials. The extraction was performed in 
a standard 1.5 ml vial using 1 ml of MTBE. After the extraction, the organic phase 
was transferred into a cone-bottomed vial, into which it was evaporated. The sample 
was then redissolved in derivatization solution, the vial was capped, heated for 
derivatization, and injected directly from the same vial (Figure 8). 
 With this technique, the initial serum volume of 150 µl was transformed into 50 
µl of derivatization solution, of which 40 µl could be injected. This translates into    
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80% recovery of the original serum volume. The extraction recovery of the assay, 
calculated as a mean of all the analytes from both male and female serum, was 85%. 
  
                  
 
Figure 8. Combined liquid-liquid extraction and oxime derivatization of serum steroids 
using two autosampler vials (IV). (a) The sample preparation process. (b) A serum 
sample spiked with IS solution, (c) after adding the MTBE, (d) after the extraction and 
5-minute equilibration time. (e) The MTBE phase transferred to a cone-bottomed vial, (f) 
the vial after solvent evaporation, (g) after reconstituting in the derivatization solution 
and heating. 
 
Thus, the overall mean analyte recovery (extraction recovery + percentage of the 
sample injected) was 68%. Once again, injecting the entire contents of the vial would 
have increased the recovery, but dispersion of the sample on the inside surface of the 
a
 
b
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g 
Transfer 150 µl of serum 
into a 1.5 ml    
autosampler vial 
Add 20 µl of IS solution, 
mix shortly 
Add 1 ml of MTBE, shake 
for 10 minutes, transfer 
the MTBE into another vial 
Evaporate to dryness 
Heat for 30 min at 60°C, 
inject for analysis 
Add 50 µl of 100 mM 
NH2OH in 50% MeOH 
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vials reduced the volume of the injectable solution to around 40 µl. The extraction 
recovery would also have been slightly higher if the samples were extracted more 
than once. However, the resulting volume of the MTBE would have necessitated 
either two evaporation cycles, or abandoning the concept of evaporation straight 
into the injection vial. As the assay usability and reliability were strongly 
emphasized, single extraction was employed. The described sample preparation 
technique resulted in fully satisfactory sensitivity after the analyte derivatization 
was supplemented into the extraction process.  
6.2 INCREASING THE MASS SPECTROMETRIC RESPONSE 
In this study, there were two major ionization-related challenges. In the first case, 
the mobile phase composition did limit the response, even though the analyte was 
permanently ionized (II). In this case, a special ionization technique was employed 
to counteract the negative effects of the mobile phase. As this technique had never 
been described for microscale analysis, an additional study was devoted to the 
characterization of the technique in microchip scale (III). In the second case, the low 
proton affinity of the analytes resulted in weak ionization and the formation of 
different adducts, irrespective of the mobile phase composition (IV). In this case, 
modification of the analyte structures was used to improve the proton affinity of the 
compounds.   
 
6.2.1  Atmospheric pressure thermospray ionization (II, III) 
As discussed in chapter 6.1.1, the mass spectrometric response for ACh was 
extensively affected by the chromatographic conditions that were needed for the 
highly polar analyte. The mostly organic mobile phase of a HILIC separation 
technique would have favored the ESI process, but due to the reasons discussed 
above, this technique could not be employed, necessitating the use of an ion-pair 
agent (TFA) and an almost completely aqueous mobile phase. Although ionization 
of the permanently cationic ACh was not of concern, the TFA-containing mobile 
phase resulted in a suboptimal ESI response. Interestingly, however, a clear ACh 
peak was seen with APCI, when the corona discharge was accidentally set to zero. 
When a discharge current was applied, the observed [M]+ ion of ACh disappeared. It 
was speculated that by using the heated APCI vaporizer without any corona 
discharge, more efficient desolvation and hence response for the analyte could be 
realized than with the ESI source. This was indeed the case. Particularly with TFA-
containing mobile phase, this technique, which was later termed atmospheric 
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pressure thermospray ionization (APTSI) produced significantly higher ion counts 
for acetylcholine than could be achieved with ESI (Figure 9).  
 
 
 
 
Figure 9. Comparison of acetylcholine signal intensity using electrospray (ESI) and 
atmospheric pressure thermospray ionization (APTSI). Mobile phase: 2% acetonitrile, 
flow rate 0.3 mL/min. 
 
Thus a novel sensitive assay for ACh was developed by combining APTSI with the 
previously discussed ion-pair chromatography. The use of APCI source in this 
unconventional manner has been previously reported in few papers (Turnipseed et 
al., 2006; Andersen et al., 2009; Favretto et al., 2010). Its favorability for ACh analysis 
or mobile phases containing TFA has not been previously described.  
 
APTSI in microchip scale 
Increasing the ACh assay sensitivity further to enable the analysis of samples 
without acetylcholinesterase may be difficult, without changing the described 
instrumentation. For instance, sensitivity improvements that could be achieved by 
downscaling of the separation system volumes are limited by the size of the 
employed ion source; as discussed earlier, only ESI sources are commercially 
available in capillary or microchip scale. However, shortly after the ACh assay 
development, the opportunity arose to use the experimental heated microchip 
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nebulizer mentioned in chapter 2.2 (Saarela et al., 2007). When attached to a nano-
ESI adapter probe originally designed to enable ESI spraying directly from a 
capillary column (Figure 10), the microchip could be operated inside a closed ion 
source housing as a miniature APCI source (Figure 11).   
 
 
 
 
Figure 10. Photographs of the standard APCI ion source probe and the microchip 
heated nebulizer used for the miniature APTSI experiments. (a) Electrical wires for the 
resistive heating of the microchip, (b) fused silica sample inlet capillary, (c) platinum 
heater wire, (d) vaporizer gas tubing, (e) vaporizer channel and the nozzle of the 
microchip.  
 
 
 
e 
d 
c 
b 
Standard Thermo APCI probe 
Microchip nebulizer attached to a modified 
New Objective PicoFrit probe 
a 
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Figure 11. Positioning of the microchip nebulizer inside a Thermo ion source housing 
 
 
 
Nozzle of the 
microchip 
Orifice of the ion 
transfer capillary 
Attachment for the APCI 
corona discharge needle; 
needle removed 
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As the first prototype of the microchip had been already successfully used for APCI 
and APPI (Östman et al., 2004; Kauppila et al., 2004b), the feasibility of utilizing the 
later version for APTSI was studied. Similarly to the previous experiments with a 
standard APCI source, the [M]+ ion was observed for ACh when the corona 
discharge was turned off. The most suitable flow rate was 2–20 µl/min in contrast 
with the 200 µl/min that was used for the ACh assay.  
 In an attempt to further characterize this novel ionization technique, several 
additional compounds were included in the study and the comparisons were made 
with microchip-APCI and standard ESI. As a result, the microchip-APTSI (µAPTSI) 
was found to produce ESI-like spectra, with weaker overall intensities but 
remarkably good signal-to-noise ratios that were comparable with the standard-
sized ESI. For instance, for the test compound ofloxacin (Figure 6), similar S/N ratios 
were observed, despite the 10-times greater response of ESI. The test compound 
spectra were comparable with ESI, showing adduct ions and multiple charging of 
peptides, as demonstrated with angiotensin II. In addition, similarly to the earlier 
results with the standard-sized APTSI, the microchip-APTSI was found to tolerate 
well the ion-suppressing mobile phase constituents, including TFA and ammonium 
salts of formic and acetic acid. It also favored the use of a mobile phase with a high 
organic content, like ESI, being suitable for use with HILIC separations.  
 Although the aim of the study was not to investigate the theoretical 
mechanisms of the APTSI ionization process, the results suggest that at least in its 
microchip variation, the ion formation proceeds through ion evaporation or charged 
residue process. The inability of APTSI to ionize non-polar test compounds, such as 
6-ketocholestanole, and the strong response for quaternary ammonium compounds 
are comparable to ESI and in contrast with APCI. Moreover, the disappearance of 
the signal when high nebulizer temperatures were applied implies that, after 
reaching a certain temperature, complete vaporization of the solution occurs and the 
ionization process driven by the shrinkage of droplets is no longer realized. The 
subject is discussed in more detail in the paper III.  
 Overall, the results indicate that APTSI ionization can be used as an alternative 
ionization technique also on a smaller scale, in combination with capillary 
separation systems. With the studied microchip, the separation column could be 
integrated into the fused silica inlet capillary, or within the chip structure. This 
opens interesting new options especially for the development of more sensitive ACh 
assays, since in theory the smaller dimensions of the microchip source would result 
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in sensitivity advances. However, direct comparison of the chip and a standard 
APCI source was not made using the mobile phase composition of the ACh assay. 
 
6.2.2 Derivatization of the analytes for increased proton affinity (IV) 
All the analytes in the serum steroid assay were poorly ionized with ESI. Using 
positive polarity, [M+H]+ ions were observed, but the adduct formation was 
pronounced, even if the mobile phase consisted of solvents and reagents of MS 
grade. This is a well known phenomenon for steroid compounds (Ma and Kim, 
1997). However, it was not possible to use these adduct ions as precursors as the 
product ions were left uncharged and were not detected. Loss of water was also 
evident for compounds with a hydroxyl group in 3-position (pregnenolone, 17-OH-
pregnenolone, and DHEA), likely resulting in the formation of conjugated double 
bond between carbons 3 and 4 (Figure 6).  
 In some cases, the ESI response of underivatized steroids can be improved by 
adding ammonia to the mobile phase to suppress the adduct formation (Leinonen et 
al. 2002; Saito et al., 2010). Although this can increase the amount of [M+H]+ ions, the 
inherent weak gas phase proton affinities of steroids remain and many factors, 
including the proton affinity of the organic solvent used for the mobile phase, have 
a significant effect on the ion intensity (Ma and Kim, 1997).  
 With derivatization, however, the ionization efficiency of the analytes can be 
modified, which has particular importance for ESI based methods, where the gas 
phase proton affinities of all the sample and mobile phase components contribute to 
the analyte ion intensity (Amad et al. 2000). In the present case, all the analytes had 
ketone functionality, which was indicative of the suitability for the recently 
introduced oxime derivatization technique to increase the proton affinity of the 
analytes (Liu, Sjövall, Griffiths, 2000). Indeed, the reaction was fast and efficient and 
had a substantial positive effect on the mass spectrometric response of all the 
analyzed compounds, resulting in 1.7–16 fold increase in the analyte [M+H]+ 
intensities  (Figure 12). 
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Figure 12. The effect of derivatization on the [M+H]+ ion intensity of ketosteroids 
 
After derivatization, the steroids were detected as [M+H]+ ions, without adducts 
(Figure 13), and with loss of water only evident for 17-OH-pregnenolone. The 
derivatives were stable when stored in the reaction mixture at ambient temperature, 
allowing the derivatization to be made up to 18 hours before the sample analysis. 
Moreover, since the derivatization reaction mixture could be injected without any 
additional clean-up procedures, it provided a simple and efficient method for 
improving the analyte ionization, without adding unnecessary complexity to the 
assay.  
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Figure 13. The effect of oxime derivatization on the spectra of selected ketosteroid 
analytes. The spectra are marked (a) before and (b) after the derivatization. 1: 
testosterone, 2: pregnenolone, 3: DHEA. 
 
6.3 DEVELOPED ASSAYS 
The next paragraphs provide a brief discussion of each developed assay regarding 
the method development, validation, and routine use. The performance 
characteristics related to the study objectives are presented in Table 4. More detailed 
results of the method performance and validation results are described in the 
individual papers. 
[M+Na]+ 
1a 
 
[M+H]+ 
[M+K]+ 
1b 
 
[M+H]+ 
 
2b 
[M+H]+ 
3b 
 
[M+H]+ 
2a 
 
[M+H]+ [M-H2O+H]
+ 
[M+Na]+ 
3a 
 
[M+H]+ [M-H2O+H]
+ 
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Table 4. Summary of the assays developed in the study 
aExtraction recovery  
bPercentage of available sample injected on column 
cCombined extraction and injection recovery 
 
Tamsulosin (I) 
Tamsulosin is an exogenous compound, which as per FDA guidance requires matrix 
based standard samples for quantification and demonstration of the assay selectivity 
and accuracy. However, due to ethical reasons, such amount of samples cannot be 
obtained. In the presented case, the availability of blank AH was limited to a single 
patient that was not receiving tamsulosin. This sample was used for selectivity and 
accuracy studies, but was not sufficient for the calibration and quality control (QC) 
purposes as described in the FDA guidance. Therefore, water was used as a 
surrogate matrix. The AH samples that were used for the stability studies were from 
the operation of the other eye of the patients enrolled in the study, if both eyes were 
operated.  
 At the time of the study, stable isotope labeled tamsulosin was not available. 
Instead, labetalol was used as an IS, because of its structural similarity with 
tamsulosin (Figure 6). Uniform ionization environment for both compounds was 
achieved through chromatographic coelution. However, because labetalol is an 
antihypertensive drug, some clinical samples may contain this drug. In the study in 
question, the medication of all the enrolled patients was known and did not include 
labetalol, justifying its use as an IS. Nonetheless, to ensure the compatibility of the 
assay with a broader range of clinical samples, the use of isotope labeled tamsulosin 
would have been desirable. This underlines the importance of careful IS selection for 
drug analysis if isotope labeled analogues are not available. Many structurally close 
compounds that are commercially available and could be used as an IS are also 
drugs or drug metabolites and may potentially be present in the patient samples. 
 In the tamsulosin assay, no comprehensive study of the ME was performed. 
However, since the absolute recovery from serum was around 70% (combination of 
Assay 
Sample 
Ionization LC–MS 
Recovery LLOQ 
preparation Extracta Injectb Totalc (ng/mL) 
Tamsulosin 
(I) 
Direct  
injection 
(+)ESI 
RP, 
Linear IT 
– 70 % 70 % 0.08 
        Acetylcholine 
(II) 
Direct 
 injection 
(+)APTSI 
Ion-pair, 
Linear IT 
– 67 % 67 % 0.02 
        Steroids 
(IV) 
LLE,  
derivatization 
(+)ESI 
RP, 
QQQ 
85 % 80 % 68 % 0.01–0.10 
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extraction recovery and the possible ME, calculated by comparing pure standard 
solution with extracted sample), this points to the absence of strong ion suppression. 
In the AH samples, ME was not studied due to the shortage of blank sample 
material. However, assaying the spiked blank AH against water based standards 
resulted in adequate accuracy, indicating that if present, the ion suppression was at 
an acceptable level. 
 Using dedicated standard samples and separate quantification, both serum and 
AH samples could be analyzed within the same run. During the tamsulosin 
medication, the concentrations in the serum samples were expectedly high (mean 
concentration 12.7 ng/ml or 31.1 nM), whereas the AH levels were low (mean 
concentration 0.4 ng/ml or 0.98 nM). Since the LLOQs for serum and AH were 0.1 
ng/ml (0.25 nM) and 0.08 ng/ml (0.20 nM), respectively, the concentrations of 
tamsulosin were well within the sensitivity limits of the assay. After a pause of 7–28 
days in the tamsulosin medication, most of the AH samples still had concentrations 
above LLOQ (Pärssinen et al., 2006). However, to further study the kinetics and the 
clearance of tamsulosin from the eye, more sensitive assay would be needed. It is 
noteworthy that the sensitivity of the ion trap MS used for this study was not 
comparable with the current QQQ instruments. However, this was the first 
published assay for the determination of tamsulosin from the human AH, revealing 
the ophthalmic penetration of the drug and its prolonged presence in the anterior 
chamber of the eye, which had been recently found to complicate eye operations.  
 
Acetylcholine (II) 
At the time of its publication, the ACh assay was the first to use a stable isotope 
labeled IS. Unlike the AH assay for tamsulosin, the availability of microdialysis 
samples enabled the careful validation of the method. In this study, the absence of 
sensitivity-affecting ME could be proved (Figure 14).  
 Probably due to the special ionization technique, the concentration range of the 
assay was wider than in any of the previously published ESI based methods, 
ranging from 0.15 nM (0.02 ng/ml) to 73 nM (10.7 ng/ml). The assay was used for the 
determination of hippocampal levels of ACh in the rats treated to mimic Alzheimer’s 
disease (Ihalainen et al, 2010; Ihalainen et al, 2011). All the study samples were 
within the standard curves, requiring however, the full use of a wide concentration 
range as the concentrations in the study samples were between 0.3 and 70 nM (0.04–
10.2 ng/ml).    
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          Ion suppression time window 
 
 
 
Figure 14. A post-column infusion chromatogram after injecting a rat brain 
microdialysate sample. APTSI ionization, MRM transition of ACh monitored. Retention 
time for ACh: 1.35 min. 
 
Although the sensitivity of the developed assay enabled the collection of small-
volume samples, which enabled fine temporal resolution of the microdialysis 
experiment, an acetylcholinesterase inhibitor was needed in the perfusion fluid to 
prevent the enzymatic breakdown of ACh. This technique is commonly used to 
increase the ACh levels in the microdialysis samples, but it is also controversial, as 
the inhibitors may leak into the studied tissues and contribute to the biological 
processes. For the measurement of ACh in the perfusates that do not contain 
inhibitors, assays with significantly greater sensitivity are needed.   
  
Steroids (IV) 
In addition to the improvements in sensitivity in the ketosteroid analysis, the oxime 
derivatization also improved the chromatographic selectivity, increasing the number 
of analytes that could be included in the assay. Under identical chromatographic 
conditions, the peaks of testosterone, 17-hydroxyprogesterone, and 
dehydroepiandrosterone were overlapping, but became baseline-separated after 
derivatization (Figure 15). This was important, as MS/MS selectivity could not be 
obtained for these compounds due to their isobaric precursor ions or similar 
fragmentation patterns.   
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Figure 15. Separation of testosterone, 17-hydroxyprogesterone, and 
dehydroepiandrosterone after their derivatization to oximes. Identical chromatographic 
method in both runs. Details of the separation system and conditions are described in 
paper IV. 
 
Depending on the analyte, the LLOQs were between 0.03 and 0.34 nM (0.01−0.10 
ng/ml), enabling the analysis of all of the included steroids from adult female and 
male serum. However, some important analytes had to be excluded due to their 
insufficient response. Dihydrotestosterone could be measured from males, but not 
from females. This compound, as well as androstanedione that could not be 
detected from the serum of either sex, showed pronounced separation of the oxime 
isomers, which resulted in decrease of peak height (Figure 16). Estrone was 
detectable in the serum of both sexes, but its low levels resulted in poor precision. 
Androsterone could not be chromatographically separated from its biologically 
active isomer etiocholanolone. It also produced fragmentation that was identical 
with etiocholanolone and hence these two coumpound could not be included in the 
assay. Despite the shortcomings in the analysis of these compounds, the steroid 
assay was the first to describe a simultaneous analysis of all of the main ketosteroid 
metabolites of progestagen and androgen groups in both female and male serum. 
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Figure 16. Formation of chromatographically separable isomers during oxime 
derivatization. Identical chromatographic method in both runs. Details of the separation 
system and conditions are described in paper IV. 
 
The ketosteroid assay was used for the serum steroid profiling of endometriosis 
patients (n=155) and healthy controls (n=64). All the included analytes could be 
reliably assayed with a typical throughput of 90–100 samples per day. The high 
sensitivity of the assay was essential for the successful analysis of progesterone, 17-
hydroxyprogesterone, and 17-hydroxypregnenolone. 
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7 Summary and conclusions 
In this thesis, different techniques to increase the sensitivity of bioanalytical LC–MS 
assays were studied. The experimental work was focused on improving the sample 
preparation and the analyte ionization, with two different approaches taken for both 
stages of an assay. For the aqueous, protein-deficient samples with a volume below 
50 µL, direct injection was employed. For the larger serum samples that could not be 
injected as such, small-scale LLE technique was developed. Ionization of 
permanently charged analyte ACh was improved by using a novel APTSI technique. 
For poorly ionized ketosteroids, oxime derivatization was used in conjunction with 
ESI. The techniques were implemented in three complete assays, with validation and 
sample analysis data to support the evaluation of their performance. In addition, the 
feasibility of using the APTSI technique at the microchip scale was evaluated in a 
preliminary manner prior to further studies.  
 The assays demonstrate the feasibility of direct injection for aqueous samples 
with a low protein content, such as AH or brain microdialysate. Diluting the sample 
with IS increases the analyte recovery by diluting the solution that remains in the 
vial after the injection. However, the injection volumes are limited by the analyte 
polarity and column capacity. Increasing the injection volumes may not be a feasible 
option when very small columns or particles with low mass loading capacities are 
employed. Direct injection of aqueous samples also relies on RP or ion-pair 
chromatography, since injection of aqueous samples into a HILIC column is not 
feasible. For the serum samples that required sample pre-processing, LLE was used. 
In the case of steroid analysis that required derivatization in addition to the 
extraction, minimal sample loss was achieved by performing the entire process 
using only two autosampler vials. This method is also feasible with large injection 
volumes, though having the same limitations related to the capacity of the 
separation column as the methods based on direct injection.    
 APTSI was found to be a remarkably suitable ionization technique for ACh 
analysis, enabling the use of TFA in the mobile phase without ion-suppression. 
Experiments with a heated microchip nebulizer highlighted the feasibility of using 
APTSI with the microchip technique, enabling its use in combination with 
microscale separation systems. For the first time, APTSI was compared against APCI 
and ESI, and was found to result in ESI-like ionization of various compounds that 
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can be charged in solution. The low noise and the tolerance for ion-suppressing 
mobile phase additions seem to be the major advantages of this ionization technique 
over ESI. For the ketosteroid analytes with weak proton affinity, oxime 
derivatization was used. This resulted in improved ionization efficiency, permitting 
the use of ESI. The derivatization reaction could be efficiently incorporated into the 
LLE process, maintaining the high analyte recovery of the sample preparation 
method. 
 
Future perspectives 
The advantages of APTSI should be fully probed. The studies with APTSI and 
different mobile phase additives suggest that APTSI may be less sensitive to matrix 
based ion-suppression than ESI. In this case, APTSI could represent a feasible 
alternative to ESI, when APCI and APPI cannot be used. In addition, a direct 
comparison of standard-sized APTSI with ESI, APCI, and APPI would allow its 
establishment among the other ionization techniques.     
 Due to the decreased dimensions, a microchip APTSI in combination with a 
capillary column should offer significantly improved sensitivity for ACh analysis. 
Performance characterization of the described setup in an analytical setup is needed 
to allow comparisons against standard-sized systems. If the increase in sensitivity is 
sufficient to allow the quantification of the baseline ACh levels in rat brain without 
requiring the inclusion of acetylcholinesterase inhibitors in the perfusion fluid, it 
would be the preferred technique. In addition, the smaller injection volumes 
possible with the capillary systems would allow smaller sample volumes and 
greater sampling frequency, increasing the temporal resolution of the microdialysis 
experiments. However, it must be noted that the performance of the experimental 
microchip used in this study was not optimal when the amount of organic solvent in 
the mobile phase was below 10%. This indicates that the design of the microchips, 
such as the efficiency of the heater and the type and dimensions of the vaporizer 
may have strong effect on their performance. 
 In the present study, the IS dilution and mixing were performed manually in 
the vials using a micropipette. To increase the method throughput, this step could be 
performed using the autosampler functions. This would enable the collection of the 
samples directly into the vials or well plates and their subsequent analysis without 
any need to manually process the samples. 
 The described oxime derivatization method can only be used for compounds 
containing a ketone functionality. Consequently, ionization of some steroids of 
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significant biological importance, such as estradiol, cannot be improved with this 
technique. Other derivatization techniques exist, but they are not compatible with 
the steroids described in this study. However, there is a great need for the 
simultaneous measurement of estradiol and ketosteroids. To achieve this goal, an 
approach different from the one described in this study would be needed. The use of 
APPI is a promising alternative to older techniques in the analysis of underivatized 
steroids, and together with suitable derivatization, further increase in the sensitivity 
may be obtained, with the ability to analyze a greater range of steroids.  
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